Prevalence of hepatitis C among pregnant females attending antenatal clinic at a tertiary care hospital in Lucknow, Uttar Pradesh, India


  • Noor Jahan Department of Microbiology, Integral Institute of Medical Sciences and Research, Integral University, Lucknow, Uttar Pradesh, India
  • Nitin Chaudhary Department of Medical Microbiology, Saaii College of Medical Science and Technology, Chaubepur, Kanpur, Uttar Pradesh, India
  • Asma Nigar Department of Obstetrics and Gynaecology, Integral Institute of Medical Sciences and Research, Integral University, Lucknow, Uttar Pradesh, India
  • Siraj Ahmad Department of Community, Medicine Integral Institute of Medical Sciences and Research, Integral University, Lucknow, Uttar Pradesh, India
  • Razia Khatoon Department of Microbiology, Hind Institute of Medical Sciences, Mau, Ataria, Sitapur, Uttar Pradesh, India
  • Anil Kumar Department of Medical Microbiology, Vananchal Dental College and Hospital, Garhwa, Jharkhand, India



Enzyme-linked immunosorbent assay, Hepatitis C, Pregnant females, Prevalence


Background: Hepatitis C virus (HCV) is a major causative agent of parenterally acquired hepatitis. Vertical transmission of HCV occurs from mother to infant during pregnancy, delivery, or neonatal period. Hepatitis C infection among pregnant females can adversely affect both mother and fetus, leading to chronic infection in infants who later develop liver cirrhosis and hepatocellular carcinoma. Objective of the study was to evaluate the prevalence of hepatitis C among pregnant females attending antenatal clinic.

Methods: A hospital based cross-sectional study was done over a period of six months from January to June 2019. A total of 550 pregnant females were included in the study who attended Antenatal Clinic for routine check-up and whose blood samples were sent to Microbiology Laboratory for screening of anti-HCV antibodies by Enzyme linked Immunosorbent Assay (ELISA) method.

Results: Out of 550 pregnant females tested, 3 were found to be reactive to anti-HCV antibodies by ELISA; hence the prevalence was found to be 0.5%. All 3 seropositive females belonged to age group 26-35 years, were indoor patients (IPD) and belonged to lower socio-economic class. Majority of seropositive females belonged to urban areas (66.7%, 2/3) as compared to those from rural areas (33.3%, 1/3).

Conclusions: Although, prevalence of hepatitis C was found to be less among pregnant females attending ANC of this institute, still routine screening of all pregnant females for anti-HCV antibodies is highly recommended, for timely detection of disease in mothers and prevention of its transmission to infants.


Eriksen NL. Perinatal consequences of hepatitis C. Clin Obstet Gynecol. 1999;42:121-33.

World Health Organization: Hepatitis C. WHO Fact Sheet. 2019. Available at: Accessed on 11 September 2019.

Hughes BL, Page CM, Kuller JA. Hepatitis C in pregnancy: Screening, treatment, and management. Am J Obstetr Gynecol. 2017;217:B2-B12.

Spera AM, Eldin TK, Tosone G, Orlando R. Antiviral therapy for hepatitis C: has anything changed for pregnant/lactating women? World J Hepatol. 2016;8:557-65.

Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period–are they opportunities for treatment? J Viral Hepat. 2011;18:229-36.

Reddick KLB, Jhaveri R, Gandhi M, James AH, Swamy GK. Pregnancy outcomes associated with viral hepatitis. J Viral Hepat. 2011;18:394-8.

Steinmann E, Pietschmann T. Cell culture systems for hepatitis C virus. Curr Top Microbiol Immunol. 2013;369:17-48.

Simmonds P. The origin of hepatitis C virus. Curr Top Microbiol Immunol. 2013;369:1-15.

Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Narkewicz MR, Roberts EA, et al. NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents. J Pediatr Gastroenterol Nutr. 2012;54:838-55.

Ceci O, Margiotta M, Marello F, Francavilla R, Loizzi P, Francavilla A, et al. Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr. 2001;33:570-5.

Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005;192:1880-9.

Shebl FM, El-Kamary SS, Saleh DA, Abdel-Hamid M, Mikhail N, Allam A, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol. 2009;81:1024-31.

Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61:1-32.

Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013;10:553-62.

Kato N. Genome of human hepatitis C virus (HCV): Gene organization, sequence diversity, and variation. Microb Comp Genomics. 2000;5:129-51.

Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatol. 2013;57(4):1333-42.

Rantala M van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill. 2008;13(21):18880.

Duberg A, Janzon R, Bäck E, Ekdahl K, Blaxhult A. The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill. 2008; 13(21):18882.

Kumar A, Sharma KA, Gupta RK, Kar P, Chakravarti A. Prevalence and risk factors for hepatitis C virus among pregnant women. Indian J Med Res. 2007;126:211-5.

Jaffery T, Tariq N, Ayub R, Yawar A. Frequency of hepatitis C in pregnancy and pregnancy outcome. J Coll Physicians Surg Pak. 2005;15:716-9.

World Health Organization. Global distribution of hepatitis A, B, and C. Wkly Epidemiol Rec. 2002;77:45-7.

Boxall E, Skidmore S, Evans C, Nightingale S. The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiol Infect. 1994;113:523-8.

Goldberg D, McIntyre PG, Smith R, Appleyard K, Dunlop J, Taylor A, et al. Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing. BJOG. 2001;108:365-70.

Sood A, Midha V, Bansal M, Sood N, Puri S, Thara A. Perinatal transmission of hepatitis C virus in northern India. Indian J Gastroenterol. 2012;31:27-9.

Le Campion A, Larouche A, Fauteux-Daniel S, Soudeyns H. Pathogenesis of hepatitis C during pregnancy and childhood. Viruses 2012;4:3531-50.

Parthiban R, Shanmugam S, Velu V, Nandakumar S, Dhevahi E, Thangaraj K, et al. Transmission of hepatitis C virus from asymptomatic mother to child in southern India. Inter J Infect Dis. 2009;13:e394-400.

Upreti P, Singh RK, Arya V. Burden of HCV infection among pregnant women with assessment of risk factors and pregnancy outcome in HCV infected: A hospital based study from Uttarakhand. J Med Sci Clini Res. 2017;5:17249-56.

Pyadala N, Maity SN, Kothapalli J, Goud AK, Borugadda R, Mallepaddi PC, et al. Seroprevalence of HCV infection among pregnant women in a rural teaching hospital, Sangareddy. Inter J Res Develop Pharmacy Life Sci. 2016;5:2251-4.

Goyal LD, Kaur S, Jindal N, Kaur H. HCV and Pregnancy: Prevalence, risk factors, and pregnancy outcome in North Indian Population: A Case–Control Study. J Obstetr Gynecol India. 2014;64:332-36.






Original Research Articles